IP Library Granted Patent US 9,663,704
Granted Patent B2
US 9,663,704 · App. 14/364,064 · Granted May 30, 2017

Process for the enhanced recovery of oil by injection of a polymer solution

Inventor: Cedrick Favero (Saint Romain le Puy, FR)
Assignee: S.P.C.M. SA
C09K8/588C08F220/56E21B43/16C08F220/34C08F220/58C08F226/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,663,704
App. No.
14/364,064
Granted
May 30, 2017
Kind
B2
Abstract

Process for the enhanced recovery of oil comprising introducing into an injection fluid at least one linear or structured water-soluble copolymer obtained by polymerization of 2-acrylamido-2-methylpropane sulfonic acid monomer in free acid and/or salified form with acrylamide derivative monomers having the formula H 2 C═CR—C(═O)-A in which R is H or CH 3 or CH 2 COOR′, wherein R′ is an alkyl containing not more than 3 carbon atoms, and A is selected from the group consisting of 2-pyrrolidone, pyrrolidine and 4-morpholine, and injecting the injection fluid, which is then viscosified, into a reservoir, and thereafter recovering the aqueous and oily and/or gaseous mixture.

Claims (54)

1. Process of enhanced oil recovery, comprising:

(a) introducing into an injection fluid at least one linear or structured water-soluble copolymer obtained by polymerization of:

(i) 2-acrylamido-2-methylpropane sulfonic acid monomer in free acid and/or salified form, and

(ii) acrylamide derivative monomers of formula (I):

in which

(iii) R═H or CH 3 or CH 2 COOR′, wherein R′ is an alkyl containing not more than 3 carbon atoms, and

(iv) A is selected from the group consisting of 2-pyrrolidone, pyrrolidine and 4-morpholine;

(b) injecting the injection fluid, which is then viscosified, into a reservoir; and

(c) recovering the aqueous and oily mixture.

2. Process according to claim 1 , wherein the salified form of the monomer 2-acrylamido-2-methylpropane sulfonic acid is an alkali metal salt selected from the group consisting of a sodium salt, a potassium salt, an ammonium salt, an amino alcohol salt and an amino acid salt.

3. Process according to claim 1 wherein the water-soluble copolymer is obtained by polymerization of:

(a) more than 5 mol % and strictly less than 60 mol % of monomer 2-acrylamido-2-methylpropane sulfonic acid in free acid and/or salified form; and

(b) strictly more than 10 mol % and less than 95 mol % of monomer of formula (I).

4. Process according to claim 3 wherein the water-soluble copolymer is obtained by polymerization of from 10 mol % to 50 mol % of monomer 2-acrylamido-2-methylpropane sulfonic acid in free acid and/or salified form.

5. Process according to claim 3 wherein the water-soluble copolymer is obtained by polymerization of from 15 mol % to 70 mol % of monomer of formula (I).

6. Process according to claim 1 wherein the water-soluble copolymer is obtained by polymerization of:

(a) from 15 mol % to 40 mol % of monomer 2-acrylamido-2-methylpropane sulfonic acid; and

(b) from 20 mol % to 60 mol % of monomer of formula (I).

7. Process according to claim 6 wherein the water-soluble copolymer is obtained by polymerization of from 20 mol % to 30 mol % of monomer 2-acrylamido-2-methylpropane sulfonic acid.

8. Process according to claim 6 wherein the water-soluble copolymer is obtained by polymerization of from 25 mol % to 50 mol % of monomer of formula (I).

9. Process according to claim 1 wherein the water-soluble copolymer further comprises at least one hydrophilic monomer selected from the group consisting of:

(a) non-ionic monomers selected from the group consisting of acrylamide, methacrylamide, N,N-dimethylacrylamide, N-vinylpyrrolidone, N-vinyl formamide, polyethylene glycol methacrylates, diacetoneacrylamide, N-isopropylacrylamide, 2-hydroxyethyl acrylate, 2,3-dihydroxypropyl acrylate, 2-hydroxyethyl methacrylate, 2,3-dihydroxypropyl methacrylate; and/or

(b) anionic monomers selected from the group consisting of acrylic acid, methacrylic acid, itaconic acid, maleic acid, non-salified, partially or completely salified; and/or

(c) cationic monomers selected from the group consisting of diallyldimethylammonium chloride (DADMAC), dialkylaminoethyl acrylate (DAMEA), and dialkylaminoethyl methacrylate (DAMEMA), acrylamido dialkylaminopropyl, methacrylamido dialkylaminopropyl and their acidified or quaternized salts.

10. Process according to claim 1 wherein the water-soluble copolymer further comprises at least one monomer of hydrophobic nature selected from the group consisting of N-alkylacrylamides, dialkylacrylamides and 25-ethoxylated behenyl methacrylate.

11. Process according to claim 1 wherein the water-soluble copolymer represents from 20 ppm to 5000 ppm relative to the weight of the injection fluid.

12. Process according to claim 11 wherein the water-soluble copolymer represents from 300 ppm to 4,000 ppm relative to the weight of the injection fluid.

13. Process of enhanced oil recovery, comprising:

(a) introducing into an injection fluid at least one linear or structured water-soluble copolymer obtained by polymerization of:

(i) 2-acrylamido-2-methylpropane sulfonic acid monomer in free acid and/or salified form, and

(ii) an acrylamide derivative monomer selected from the group consisting of acryloylpyrrolidone, acryloylpyrrolidine and acryloylmorpholine;

(b) injecting the injection fluid, which is then viscosified, into a reservoir; and

(c) recovering the aqueous and oily mixture.

14. Process according to claim 13 wherein the salified form of the monomer 2-acrylamido-2-methylpropane sulfonic acid is an alkali metal salt selected from the group consisting of a sodium salt, a potassium salt, an ammonium salt, an amino alcohol salt and an amino acid salt.

15. Process according to claim 13 wherein the water-soluble copolymer is obtained by polymerization of:

(a) more than 5 mol % and strictly less than 60 mol % of monomer 2-acrylamido-2-methylpropane sulfonic acid in free acid and/or salified form; and

(b) strictly more than 10 mol % and less than 95 mol % of said acrylyamide derivative monomer.

16. Process according to claim 13 wherein the water-soluble copolymer further comprises at least one hydrophilic monomer selected from the group consisting of:

(a) non-ionic monomers selected from the group consisting of acrylamide, methacrylamide, N,N-dimethylacrylamide, N-vinylpyrrolidone, N-vinyl formamide, polyethylene glycol methacrylates, diacetoneacrylamide, N-isopropylacrylamide, 2-hydroxyethyl acrylate, 2,3-dihydroxypropyl acrylate, 2-hydroxyethyl methacrylate, 2,3-dihydroxypropyl methacrylate; and/or

(b) anionic monomers selected from the group consisting of acrylic acid, methacrylic acid, itaconic acid, maleic acid, non-salified, partially or completely salified; and/or

(c) cationic monomers selected from the group consisting of diallyldimethylammonium chloride (DADMAC), dialkylaminoethyl acrylate (DAMEA), and dialkylaminoethyl methacrylate (DAMEMA), acrylamido dialkylaminopropyl, methacrylamido dialkylaminopropyl and their acidified or quaternized salts.

17. Process according to claim 13 wherein the water-soluble copolymer further comprises at least one monomer of hydrophobic nature selected from the group consisting of N-alkylacrylamides, dialkylacrylamides and 25-ethoxylated behenyl methacrylate.

18. Process according to claim 13 wherein the water-soluble copolymer represents from 20 ppm to 5000 ppm relative to the weight of the injection fluid.

19. Process according to claim 13 wherein the water-soluble copolymer represents from 300 ppm to 4,000 ppm relative to the weight of the injection fluid.

20. Process of enhanced oil recovery, comprising:

(a) preparing in the absence of a stabilizing agent an aqueous solution of at least one linear or structured water-soluble copolymer obtained by polymerization of:

(i) 2-acrylamido-2-methylpropane sulfonic acid monomer in free acid and/or salified form, and

(ii) acrylamide derivative monomers of formula (I):

in which

(iii) R═H or CH 3 or CH 2 COOR′, wherein R′ is an alkyl containing not more than 3 carbon atoms, and

(iv) A is selected from the group consisting of 2-pyrrolidone, pyrrolidine and 4-morpholine;

(b) introducing the aqueous solution into an injection fluid:

(c) injecting the injection fluid, which is then viscosified, into a reservoir; and

(d) recovering the aqueous and oily mixture.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 19, 2014
From: FAVERO, CEDRICK
To: S.P.C.M. SA
Reel/Frame 033140/0902 →
Priority Claims (1)
FR 12 50582 · Jan 20, 2012 · national
Continuity (1)
Related Publication 20140326457A1 · Nov 6, 2014